Cohort study for the relationship between aldosterone, homocysteine, endothelin-1 and new-onset atrial fibrillation after coronary artery bypass grafting

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023260

Enrollment

Unknown

Registered

2019-05-19

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary atherosclerotic heart disease

Interventions

atrial fibrillation group and non-atrial fibrillation group:No intervention

Eligibility

Sex/Gender

All

Age

15 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 Aged 18-75 years; 2 Preoperative sinus rhythm; 3 Non-emergency separate CABG.

Exclusion criteria

Exclusion criteria: 1 Patients who has a history of atrial fibrillation; 2 Patients who underwent other surgery at the same time; 3 Patients who perioperative use antiarrhythmic drugs and have placed pacemakers; 4 Patients who perioperative have severe lung function, liver function, renal function damage, tissue damage, infection, tumor, myocardial infarction; 5 Patient who combined with connective tissue disease, autoimmune diseases, coagulation system diseases and other complex non-cardiac diseases.

Design outcomes

Primary

Measure	Time frame
aldosterone, homocysteine, endothelin-1;	—

Countries

China

Contacts

Public ContactChen Yu

Peking University People's Hospital

micsc@sina.com+86 13910088749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026